|[December 19, 2012]
Robert M. Walton Appointed Chief Operating Officer at Oncology Analytics, Inc.
PLANTATION, Fla. --(Business Wire)--
Oncology Analytics, Inc. announced the addition of Robert M. Walton to
its executive team as Chief Operating Officer and to its Board of
Marc Fishman, MD, the CEO of Oncology Analytics said, "we are honored to
have a person of Mr. Walton's proven talent and experience join us in
our mission to improve cancer care quality while reducing unnecessary
costs. He will be an invaluable asset as we expand into new markets
Prior to joining Oncology Analytics, Mr. Walton served as the President
of Qualcomm (News - Alert) Enterprise Services. He has also been Senior Vice President
of National Healthplan Administration at Kaiser Permanente, a global
Vice President at Compaq Computer and a national Vice President for
Cigna Healthcare. At Oncology Analytics, Mr. Walton will oversee all
business functions including marketing, sales, commercial research and
development, IT and client services.
"I'm honored to be joining Dr. Fishman and the entire team at Oncology
Analytics (OA), and excited to be able to contriute to the continued
growth and success of the company. OA's approach to utilization
management and its business model are incredibly compelling to me. I
believe that they set a standard for how cancer care should be managed
in this country to improve outcomes, support data-based decisions,
enhance the patient experience and reduce unnecessary costs."
Mr. Walton holds a BA from the University of South Florida and a
Master's Degree from the University of Miami in Coral Gables, Florida.
He is also a graduate of executive development programs at the Stanford
Graduate School of Business in Palo Alto (News - Alert), California and the Harvard
Business School in Cambridge, Massachusetts.
About Oncology Analytics
Oncology Analytics (OA) provides web-based clinical decision support
tools to provide oncologists the essential knowledge to optimally use
cancer drugs based on the best available evidence and nationally
recognized guidelines. OA also provides cancer patients and their
physicians with the added support of a team of board certified
oncologists and support staff to ensure that physicians are providing
the best and most cost-effective treatment plan for each patient. An
active board of six practicing board certified oncologists as well as a
distinguished academic advisory board of eight renowned cancer
subspecialists back up these local resources. All these resources are
available in real time to physicians. In addition to improving the
quality of care, OA's patented system of utilization management can
diminish pharmaceutical costs by 40%, or more.
For more information, visit us on our website at www.oncologyanalytics.com,
or call 888-916-2616.
"Improving cancer care through innovative utilization management
[ Back To Technology News's Homepage ]